Veltkamp, R., Korompoki, E., Harvey, K. H., Harvey, E. R., Fießler, C., Malzahn, U., . . . Heuschmann, P. U. (2025). Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): A multicentre, open-label, randomised, phase 3 trial.
Citación estilo ChicagoVeltkamp, Roland, et al. Direct Oral Anticoagulants Versus No Anticoagulation for the Prevention of Stroke in Survivors of Intracerebral Haemorrhage With Atrial Fibrillation (PRESTIGE-AF): A Multicentre, Open-label, Randomised, Phase 3 Trial. 2025.
Cita MLAVeltkamp, Roland, et al. Direct Oral Anticoagulants Versus No Anticoagulation for the Prevention of Stroke in Survivors of Intracerebral Haemorrhage With Atrial Fibrillation (PRESTIGE-AF): A Multicentre, Open-label, Randomised, Phase 3 Trial. 2025.